IN2014CN04746A - - Google Patents

Download PDF

Info

Publication number
IN2014CN04746A
IN2014CN04746A IN4746CHN2014A IN2014CN04746A IN 2014CN04746 A IN2014CN04746 A IN 2014CN04746A IN 4746CHN2014 A IN4746CHN2014 A IN 4746CHN2014A IN 2014CN04746 A IN2014CN04746 A IN 2014CN04746A
Authority
IN
India
Prior art keywords
nktcl
jak
treating
relates
susceptibility
Prior art date
Application number
Other languages
English (en)
Inventor
Bin Tean Teh
Soon Thye Lim
Original Assignee
Singapore Health Serv Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Singapore Health Serv Pte Ltd filed Critical Singapore Health Serv Pte Ltd
Priority claimed from PCT/SG2012/000444 external-priority patent/WO2013077814A2/en
Publication of IN2014CN04746A publication Critical patent/IN2014CN04746A/en

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IN4746CHN2014 2011-11-25 2012-11-26 IN2014CN04746A (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SG2011088002 2011-11-25
PCT/SG2012/000444 WO2013077814A2 (en) 2011-11-25 2012-11-26 Natural-killer/t-cell lymphoma (nktcl) susceptibility prediction, diagnosis and therapy

Publications (1)

Publication Number Publication Date
IN2014CN04746A true IN2014CN04746A (enExample) 2015-09-18

Family

ID=54398535

Family Applications (1)

Application Number Title Priority Date Filing Date
IN4746CHN2014 IN2014CN04746A (enExample) 2011-11-25 2012-11-26

Country Status (1)

Country Link
IN (1) IN2014CN04746A (enExample)

Similar Documents

Publication Publication Date Title
MX353143B (es) Marcadores biologicos y metodos para pronosticar respuesta a antagonistas de celulas b.
EP2663656A1 (en) Genetic variants as markers for use in urinary bladder cancer risk assessment, diagnosis, prognosis and treatment
MX353186B (es) Metodos para el tratamiento, diagnosis y monitoreo de artritis reumatoide.
EA201590630A1 (ru) Способы лечения и диагностики, связанные с лизилоксидазоподобным белком 2 (loxl2)
SG195191A1 (en) Methods and compositions of predicting activity of retinoid x receptor modulator
WO2013008102A3 (en) Methods and compositions for evaluating and/or treating chronic immune diseases
MX352827B (es) Valoracion de la actividad de la ruta de señalizacion celular usando modelado probabilistico de la expresion del gen diana.
BR112013024948A2 (pt) aparelho e método para identificar estados biológicos importante em um animal
MX2016005159A (es) Metodos de diagnostico y tratamiento de trastornos eosinofilicos.
EP2601299A4 (en) SYSTEM AND DEVICE FOR TREATING CELLS
MX362514B (es) Kits y ensayos de diagnostico para la deteccion del receptor 1 de folato.
NZ601065A (en) Wnt antagonists and methods of treatment and screening
WO2011047033A3 (en) Biomarker for identification of melanoma tumor cells
EP2847709A4 (en) METHOD AND DEVICE FOR PREDICTING A PROTEIN STRUCTURE
NZ703411A (en) Use of markers in the diagnosis and treatment of prostate cancer
WO2013077814A3 (en) Natural-killer/t-cell lymphoma (nktcl) susceptibility prediction, diagnosis and therapy
MX360479B (es) Anticuerpos contra microbioma, factores de estres y marcadores de mastocitos como marcadores de diagnostico para ibs.
MX2019008005A (es) Metodos y composiciones para diagnosticar preeclampsia.
NZ729773A (en) Biomarkers for disease progression in melanoma
MX2014004025A (es) Metodos de valoracion de riesgo de lmp y aparatos relacionados.
CA2699376C (en) Gene signature for the prediction of radiation therapy response
IN2014CN04746A (enExample)
IN2014MN01795A (enExample)
MX2013012083A (es) Biomarcadores para el tratamiento de mieloma multiple.
EP2566971A4 (en) METHOD FOR DIAGNOSIS, CLASSIFICATION AND PREDICTION OF THE RISK OF DEVELOPMENT AND IDENTIFICATION OF RESPONDER AGAINST THE TREATMENT OF RHEUMATOID ARTHRITIS